FDA Advisers Recommend Anti-Opioid Overdose Drug for OTC Use

FDA Advisers Recommend , Anti-Opioid Overdose Drug for OTC Use.
'The Hill' reports that on Feb. 15,
an FDA panel voted 19-0 in favor of Naloxone
being made available over the counter.
'The Hill' reports that on Feb. 15,
an FDA panel voted 19-0 in favor of Naloxone
being made available over the counter.
Currently, the anti-opioid overdose drug
is only available with a prescription.
Sold under the brand name Narcan,
the drug is widely considered to be the
best treatment for opioid overdoses. .
It was first approved in 2015 to treat opioid overdoses in people of all ages, even newborns. .
The advisory panel agrees that there is little to no risk in making the drug available over the counter.
The advisory panel agrees that there is little to no risk in making the drug available over the counter.
There’s no reason to keep this
as a prescription, let’s get it
out there and save some lives, Elizabeth Coykendall, temporary panel member
and a paramedic in North Carolina, via 'The Hill'.
The cost of the drug has yet to be determined.
'The Hill' reports that harm reduction advocates fear it may be too expensive for groups that give it to those who need it most.
The FDA is expected to make a decision
about whether Naloxone should be made available over the counter by March 29.
The FDA is expected to make a decision
about whether Naloxone should be made available over the counter by March 29